Risk factors for dementia in Brazil: Differences by region and race

Nenhuma Miniatura disponível
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
MUKADAM, Naaheed
CARAMELLI, Paulo
LAKS, Jerson
LIVINGSTON, Gill
FERRI, Cleusa P.
Citação
ALZHEIMERS & DEMENTIA, v.19, n.5, p.1849-1857, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction Twelve risk factors (RFs) account for 40% of dementia cases worldwide. However, most data for population attributable fractions (PAFs) are from high-income countries (HIC). We estimated how much these RFs account for dementia cases in Brazil, stratifying estimates by race and socioeconomic level. Methods We calculated the prevalence and communalities of 12 RFs using 9412 Brazilian Longitudinal Study of Aging participants, then stratified according to self-reported race and country macro-regions. Results The overall weighted PAF was 48.2%. Less education had the largest PAF (7.7%), followed by hypertension (7.6%), and hearing loss (6.8%). PAF was 49.0% and 54.0% in the richest and poorest regions, respectively. PAFs were similar among White and Black individuals (47.8% and 47.2%, respectively) but the importance of the main RF varied by race. Discussion Brazil's potential for dementia prevention is higher than in HIC. Education, hypertension, and hearing loss should be priority targets.
Palavras-chave
dementia, epidemiology, prevention, risk factors
URI
https://observatorio.fm.usp.br/handle/OPI/57837
Referências
  1. Aly HAA, 2015, WHO TECH REP SER, V994, P1
  2. Ashby-Mitchell K, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.17, 10.26633/rpsp.2018.17]
  3. Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2
  4. Bertola L, 2021, EUR J NEUROL, V28, P3972, DOI 10.1111/ene.15042
  5. Brasileiro I., 2019, Estudos e Pesquisas-Informacao Demografica e Socioeconomican, V41, P1
  6. Bucholc M, 2021, ALZH DEMENT-TRCI, V7, DOI 10.1002/trc2.12122
  7. Bull Fiona C, 2020, Br J Sports Med, V54, P1451, DOI 10.1136/bjsports-2020-102955
  8. Chern A, 2019, ALZ DIS ASSOC DIS, V33, P285, DOI 10.1097/WAD.0000000000000325
  9. da Cruz MS, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00114817, 10.1590/0102-311x00114817]
  10. de Castro CP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242778
  11. Deal JA, 2017, J GERONTOL A-BIOL, V72, P703, DOI 10.1093/gerona/glw069
  12. Lima-Costa MF, 2018, AM J EPIDEMIOL, V187, P1345, DOI 10.1093/aje/kwx387
  13. Ferrite S, 2011, REV SAUDE PUBL, V45, P824, DOI 10.1590/S0034-89102011005000050
  14. Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275
  15. Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313
  16. Howard G, 2020, STROKE, V51, P742, DOI 10.1161/STROKEAHA.119.024155
  17. Instituto Brasileiro de Geogragia e Estatistica (IBGE), CARACT GER DOM MOR 2
  18. Instituto Brasileiro de Geogragia e Estatistica (IBGE), ED
  19. Instituto Brasileiro de Geogragia e Estatistica (IBGE), DIV REG BRAS
  20. Lions S, 2016, NEW DIR CHILD ADOLES, V152, P71, DOI 10.1002/cad.20158
  21. Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
  22. Livingston Gill, 2017, Lancet, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6
  23. Ma'u E, 2021, LANCET REG HEALTH-W, V13, DOI 10.1016/j.lanwpc.2021.100191
  24. Malta Deborah Carvalho, 2019, J. bras. pneumol., V45, pe20180384, DOI 10.1590/1806-3713/e20180384
  25. Melo Rodrigues PR., 2021, EPIDEMIOL SERV SAUDE, V30
  26. Mukadam N, 2019, LANCET GLOB HEALTH, V7, pE596, DOI 10.1016/S2214-109X(19)30074-9
  27. Nichols E, 2022, LANCET PUBLIC HEALTH, V7, pE105, DOI 10.1016/S2468-2667(21)00249-8
  28. Nichols E, 2019, LANCET NEUROL, V18, P88, DOI [10.1016/S1474-4422(18)30403-4, 10.1136/bmj.l94]
  29. Nitrini R, 2009, INT PSYCHOGERIATR, V21, P622, DOI 10.1017/S1041610209009430
  30. Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X
  31. Oliveira D, 2019, J ALZHEIMERS DIS, V70, pS283, DOI 10.3233/JAD-180636
  32. Pesquisa Nacional por Amostra de Domicilio (PNAD), PESS 25 AN MAIS ID S
  33. Prince M., 2015, WORLD ALZHEIMER REPO
  34. Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007
  35. Samelli AG, 2022, EAR HEARING, V43, P1416, DOI 10.1097/AUD.0000000000001205
  36. Schlesinger D, 2013, MOL PSYCHIATR, V18, P79, DOI 10.1038/mp.2011.136
  37. Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
  38. Suemoto CK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002267
  39. Topping M, 2021, SSM-POPUL HLTH, V15, DOI 10.1016/j.ssmph.2021.100841
  40. Vergara RC, 2022, ALZH DEMENT-DADM, V14, DOI 10.1002/dad2.12273
  41. Wadley VG, 2011, ANN NEUROL, V70, P229, DOI 10.1002/ana.22432

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/22
Artigos e Materiais de Revistas Científicas - LIM/45
Carregar mais